IL1B and COVID-19: Twenty COVID‐19 patients receiving 160mg of nano‐curcumin daily for 14 days showed a significant decrease (compared to the COVID‐19 patients receiving placebo) in mRNA expression of IL‐6 and IL‐1β in activated peripheral blood mononuclear cells PBMC.